🇺🇸 FDA
Patent

US 11981912

Adeno associated virus vectors for the treatment of hunter disease

granted A61KA61K38/00A61K48/005

Quick answer

US patent 11981912 (Adeno associated virus vectors for the treatment of hunter disease) held by Takeda Pharmaceutical Company Limited expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/00, A61K48/005, A61K48/0058, A61K9/0019